Allergan to sell brazikumab to AstraZeneca and Zenpep to Nestle
Allergan has agreed to sell IL-23 inhibitor brazikumab to AstraZeneca and gastrointestinal medication Zenpep (pancrelipase) to Nestle in separate agreements, as per the latest pharma acquisition news. Financial details of the two deals have not been disclosed. The divestments are being taken up in an effort to wrap up the $63 billion AbbVie acquisition of […]
Pandion bags $795m deal with Astellas for pancreas-targeted immunomodulators
November 2, 2019 No Comment
Pandion Therapeutics has bagged a $795 million worth license and collaboration deal with Japanese pharma company Astellas Pharma for the research, development, and commercialization of locally acting immunomodulators targeting autoimmune diseases of the pancreas. The collaboration will bring together the modular biologics and functional immunology expertise of Cambridge-based biotech company and Astellas Pharma’s advanced therapeutics […]
Continue reading …
Business News Today
- HDFC Bank, CSC launch EMI collection services for business correspondents
- PNC Bank to acquire payment gateway provider Tempus Technologies
- US insurtech company Joshu raises $3.7m in seed round
- Nordic Capital offers to acquire Advanz Pharma for $846m
- Aditya Birla unit to acquire stake in designer brand Sabyasachi
- PepsiCo, Beyond Meat create JV for plant-based snacks and beverages
- Surrey Bank & Trust to sell SB&T Insurance to Mountcastle Insurance
- NCR to acquire ATM operator Cardtronics for $2.5bn
- Twitter acquires email newsletter startup Revue
- Eni wins P2511 licence in 32nd UK Offshore Licensing Round
